Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2006.068114v1, 2006; 10.1373/clinchem.2006.068114
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2006.068114v1
52/7/1311    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kristensen, G. B.B.
Right arrow Articles by Sandberg, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kristensen, G. B.B.
Right arrow Articles by Sandberg, S.

Received on February 2, 2006
Accepted on April 14, 2006

Evidence-Based Laboratory Medicine and Test Utilization

Results and Feasibility of an External Quality Assessment Scheme for Self-Monitoring of Blood Glucose

Gunn B.B. Kristensen 1*, Kari Nerhus 2, Geir Thue 2, Sverre Sandberg 3

1 NOKLUS, Norwegian Quality Improvement of Primary Care Laboratories, Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway
2 NOKLUS, Section for General Practice, Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway
3 NOKLUS, Norwegian Quality Improvement of Primary Care Laboratories, Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway, and NOKLUS, Section for General Practice, Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway

* To whom correspondence should be addressed. E-mail: gunn.kristensen{at}isf.uib.no.

Background: The analytical quality of self-monitoring of blood glucose (SMBG) is not satisfactory, and the need for standardized control routines for SMBG has been underscored. The objective of this study was to investigate whether an external quality assessment scheme (EQAS) designed for office laboratories could improve the quality of SMBG measurements.

Methods: From October 2001 through March 2004, we conducted 6 glucose surveys for diabetes patients and coordinated them with an EQAS for office laboratories. Patients received 2 control samples by post twice a year. They measured each control sample in duplicate in accordance with written instructions, returned the results, and received an assessment of their analytical performance. Participants who got a poor evaluation were followed up by phone and offered guidance.

Results: Participating in an EQA program over a period of 3 years decreased the percentage of poor results among diabetes patients significantly, from 11.2% to 1.9% in the first and last surveys, respectively. Between-participant CVs improved from 5.5% to 3.7% and were comparable to results from office laboratories. It was difficult to sort out factors contributing to quality improvement.

Conclusions: Implementing a traditional EQAS among diabetes patients may improve the analytical quality of SMBG and could be convenient for motivated patients. Further evaluation of the clinical usefulness of implementing such a program is needed, however, and costs as well as limitations of current EQAS for glucose in general should be taken into account.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Association for Clinical Chemistry.